
Icosapent
All-cis-5,8,11,14,17-icosapentaenoic acid is an icosapentaenoic acid having five cis-double bonds at positions 5, 8, 11, 14 and 17. It has a role as a micronutrient, an antidepressant, an antineoplastic agent, an anticholesteremic drug, a nutraceutical, a mouse metabolite, a fungal metabolite and a Daphnia galeata metabolite. It is an omega-3 fatty acid and an icosapentaenoic acid. It is a conjugate acid of an all-cis-5,8,11,14,17-icosapentaenoate. — ChEBI
- Nom IUPAC
- (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid
- Formule moléculaire
- C20H30O2
- Masse moléculaire
- 302.5 g/mol
- Masse exacte
- 302.224580195 Da
- XLogP3
- 5,6
- Surface polaire topologique
- 37,3 Ų
- Donneurs de liaisons hydrogène
- 1
- Accepteurs de liaisons hydrogène
- 2
- Unités covalentes
- 1
- Stéréocentres définis
- 0
Également connu sous le nom de
16 autres noms signalés
Identifiants de bases de données externes
- ChEBI:CHEBI:28364
- ChEMBL:CHEMBL460026
- EPA DTXSID:DTXSID9041023
- PubMed:29968805
- PubMed:21683321
- PubMed:20671299
- PubMed:15753205
- PubMed:15619630
- PubMed:15519495
- PubMed:11347965
Preuves issues de bases de données scientifiques complémentaires
EMBL-EBI ChEBI
all-cis-5,8,11,14,17-icosapentaenoic acid
An icosapentaenoic acid having five cis-double bonds at positions 5, 8, 11, 14 and 17.
- Formule
- C20H30O2
- Masse moyenne
- 302.458 g/mol
- Masse monoisotopique
- 302.22458 Da
- Charge formelle
- 0
- icosapentaenoic acid — is a (CHEBI:36006)
- ω−3 fatty acid — is a (CHEBI:25681)
- antiviral agent — has role (CHEBI:22587)
- renoprotective agent — has role (CHEBI:231911)
- immunosuppressive agent — has role (CHEBI:35705)
- anti-obesity agent — has role (CHEBI:74518)
- micronutrient — has role (CHEBI:27027)
- nutraceutical — has role (CHEBI:50733)
- Daphnia galeata metabolite — has role (CHEBI:83038)
- anticholesteremic drug — has role (CHEBI:35821)
- mouse metabolite — has role (CHEBI:75771)
- antineoplastic agent — has role (CHEBI:35610)
- antidepressant — has role (CHEBI:35469)
- fungal metabolite — has role (CHEBI:76946)
- geroprotector — has role (CHEBI:176497)
- antirheumatic drug — has role (CHEBI:35842)
- anti-asthmatic agent — has role (CHEBI:65023)
- antipsychotic agent — has role (CHEBI:35476)
- antiviral agent — has role (CHEBI:22587)
- renoprotective agent — has role (CHEBI:231911)
- immunosuppressive agent — has role (CHEBI:35705)
- anti-obesity agent — has role (CHEBI:74518)
- micronutrient — has role (CHEBI:27027)
- nutraceutical — has role (CHEBI:50733)
- Daphnia galeata metabolite — has role (CHEBI:83038)
- anticholesteremic drug — has role (CHEBI:35821)
- mouse metabolite — has role (CHEBI:75771)
- antineoplastic agent — has role (CHEBI:35610)
- antidepressant — has role (CHEBI:35469)
- fungal metabolite — has role (CHEBI:76946)
- geroprotector — has role (CHEBI:176497)
- antirheumatic drug — has role (CHEBI:35842)
- anti-asthmatic agent — has role (CHEBI:65023)
- antipsychotic agent — has role (CHEBI:35476)
- cardiovascular drug — has role (CHEBI:35554)
- anticonvulsant — has role (CHEBI:35623)
- anti-inflammatory agent — has role (CHEBI:67079)
- gastrointestinal drug — has role (CHEBI:55324)
- icosapentaenoic acid — is a (CHEBI:36006)
- ω−3 fatty acid — is a (CHEBI:25681)
- all-cis-5,8,11,14,17-icosapentaenoate — is conjugate acid of (CHEBI:58562)
- 11421736 Source: PubMed
- 12549599 Source: PubMed
- 16643058 Source: PubMed
- 17420205 Source: PubMed
- 18459759 Source: PubMed
- 18638380 Source: PubMed
- 19036594 Source: PubMed
- 19054597 Source: PubMed
- 20014752 Source: PubMed
- 21118482 Source: PubMed
- 21274596 Source: PubMed
- 21903399 Source: PubMed
- 22260081 Source: PubMed
- 22822908 Source: PubMed
- 23920312 Source: PubMed
- 24108131 Source: PubMed
- 24238887 Source: PubMed
- 24351031 Source: PubMed
- 24387137 Source: PubMed
- 24389665 Source: PubMed
- 26784936 Source: PubMed
- 31483660 Source: PubMed
- 31618024 Source: PubMed
- 33378197 Source: PubMed
Noms supplémentaires validés
Références croisées de cette source
- CAS: 10417-94-4 — KEGG COMPOUND
- CAS: 10417-94-4 — ChemIDplus
- REGISTRY_NUMBER: 1714433 — Reaxys
- MANUAL_X_REF: 3174 — DrugCentral
- MANUAL_X_REF: C00000408 — KNApSAcK
- MANUAL_X_REF: C00001215 — KNApSAcK
- MANUAL_X_REF: C06428 — KEGG COMPOUND
- MANUAL_X_REF: D08061 — KEGG DRUG
- MANUAL_X_REF: DB00159 — DrugBank
- MANUAL_X_REF: EICOSAPENTAENOATE — MetaCyc
- MANUAL_X_REF: EPA — PDBeChem
- MANUAL_X_REF: HMDB0001999 — HMDB
- MANUAL_X_REF: LMFA01030759 — LIPID MAPS
Mis en correspondance par: Exact CAS cross-reference in the ChEBI compound record. Source mise à jour le: 2018-03-05. Récupéré le: 2026-08-31. Ouvrir la fiche source
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- LogP: 6.1 Source: DrugBank
- Physical Description: Liquid Source: Human Metabolome Database (HMDB)
- Signal: Danger Source: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] Source: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P260, P264, P280, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P321, P363, P405, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 92 reports by companies from 1 notifications to the ECHA C&L Inventory.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source
Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.
Couverture des sources complémentaires et état des correspondances
| Source | Résultat | Vérifié |
|---|---|---|
| EMBL-EBI ChEBI | Correspondance exacte | 2026-08-31 |
| NIH PubChem PUG-View | Correspondance exacte | 2026-08-31 |
Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.
Récupéré depuis NIH PubChem le 2026-08-31 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.